Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomyxoma peritonei: the 'controversial' disease.

E Galani1, G M Marx, C B Steer

  • 1Medical Oncology Department, Guy's Hospital, London, UK. eleni.galani@kcl.ac.uk

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|August 13, 2003
PubMed
Summary

Pseudomyxoma peritonei (PMP) is a rare condition causing mucinous ascites and implants. Treatment involves surgical debulking, but optimal management and outcomes for PMP remain under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.

ESMO gastrointestinal oncology·2026
Same author

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.

Asia-Pacific journal of clinical oncology·2018
Same author

A rare case of refractory disseminated leiomyomatosisperitonealis complicated by cauda equina compression.

European journal of obstetrics, gynecology, and reproductive biology·2018
Same author

Fertility sparing management of large cell neuroendocrine tumour of cervix: A case report & review of literature.

Gynecologic oncology reports·2016
Same author

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

British journal of cancer·2015
Same author

Use of the ThinPrep Imaging System for internal quality control of cervical cytology.

Cytopathology : official journal of the British Society for Clinical Cytology·2012

Area of Science:

  • Oncology
  • Gastroenterology
  • Pathology

Background:

  • Pseudomyxoma peritonei (PMP) is a rare condition characterized by mucinous ascites and peritoneal/omental implants.
  • Its etiology is unclear, with two histological subtypes: disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis (PMCA).
  • Diagnosis is often incidental during laparotomy.

Purpose of the Study:

  • To provide a comprehensive overview of Pseudomyxoma Peritonei.
  • To discuss the pathology, origin, clinical presentation, diagnosis, treatment, and prognosis of PMP.
  • To highlight the controversies in optimal management strategies.

Main Methods:

  • Review of existing literature on Pseudomyxoma Peritonei.
  • Discussion of histological classifications (DPAM vs. PMCA).

Related Experiment Videos

  • Analysis of treatment modalities including surgical debulking and chemotherapy.

    • Main Results:

    • PMP presents with variable clinical outcomes depending on histological type and treatment.
    • Radical surgical debulking and appendectomy are considered primary treatments.
    • The efficacy of intraoperative and intraperitoneal chemotherapy is under evaluation.

    Conclusions:

    • Pseudomyxoma Peritonei management requires a multidisciplinary approach.
    • Further research is needed to clarify optimal treatment protocols and improve patient outcomes.
    • Understanding the distinction between DPAM and PMCA is crucial for prognosis.